Ergonomic best practices are crucial for surgeon longevity. This primer outlines best ergonomic practices in surgery and how they can be implemented. ja.ma/3A265qS

AI is reshaping surgery, making "AI literacy" essential for surgeons Featured in the EJSO: "A Foundation for Evaluating the Surgical AI Literature" by Hashimoto et al More info on our LinkedIn page: bit.ly/4ik772B @raaudisio Andreas Karakatsanis (he/him) Isacco Montroni European Society of Surgical Oncology (ESSO) BASO~The Association for Cancer Surgery

Simone Biscaglia did it again!!! After the FIRE Trial we completed the sample size of the #AIRtrial elementrials.org/2025/01/31/mis…

1823 STEMI patients with MVD randomized to angiography-derived FFR vs. conventional angiography guidance complete revasc

A dirty secret and an ominous development Dr Feza Remzi Alessandro Fichera Phillip Fleshner MD Long‐term outcomes of ‘temporary’ defunctioning in patients with severe perianal Crohn's disease - Becker - 2025 - Colorectal Disease - Wiley Online Library onlinelibrary.wiley.com/doi/full/10.11…

Great pearls of wisdom about frailty from Cleveland Clinic Florida alumnus Nicole M Saur, MD PennSurgery #ICDS25 SIOG European Society of Surgical Oncology (ESSO) European Society of Coloproctology

We have an amazing opportunity for someone to do a 3 year IBD focused data science PhD in Edinburgh as part of a fully funded OPEN-IBD fellowship. It’s a fantastic department, in a beautiful city, and the clinical commitment will be ~20% to recruit patients to OPEN IBD with the

Will only increase in the future Neoadjuvant chemotherapy in locally advanced colon cancer: A systematic review with proportional meta-analysis - European Journal of Surgical Oncology ejso.com/article/S0748-…

youtu.be/GLMNMEh6Y68?si… I have taken care of 1000s of older pts with cancer. This video helps them and their family members to approach this decision in a more informative way Isacco Montroni

Our current thoughts on #Neoadjuvant Therapy for #Rectal #Cancer. This a very complex + continually evolving area, so thank you Annals of Surgical Oncology for the opportunity to summarize current standards and issues. link.springer.com/article/10.124…

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

Redo lap surgery for recurrent ileo-colonic CD takes longer operative time, but it’s worth! Recurrent disease is not a risk factor for conversion with similar outcomes to primary resection surgjournal.com/article/S0039-… Università di Bologna AUSL della Romagna Steven D Wexner MD, PhD Nicolas Avellaneda David T. Rubin, MD Y-SICCR

Thank you Federico Ghignone for highlighting this important SURGERY Journal publication

Repeated surgery for recurrence is not a risk factor for conversion in patients undergoing laparoscopic ileo-colonic resection for Crohn disease surgjournal.com/article/S0039-… another important SURGERY Journal publication from Federico Ghignone and Cleveland Clinic Florida alumnus Isacco Montroni 🇮🇹

Amigos gastroenterólogos/cirujanos/medicos de Cx Colorrectal Colaborativa LATAM DIVERTICULAR-LATAM , nos dan una mano contestando esta encuesta de 1 minuto liderada por Nicolas Rotholtz Oncologia Hospital Aleman . Fundamental para entender el manejo de Diverticulitis en la región. Retweet también se agradece mucho! Sociedad Paraguaya de Cirugía

A study led by Mayo Clinic surgeons shows total neoadjuvant therapy followed by surgery to treat advanced #RectalCancer leads to excellent outcomes, including low recurrence and a high percentage of cancer-specific survival. Read the study to learn more: bit.ly/3ZYAakN

Took a while and a lot of effort, but Finally the long-term outcomes of #Crohnsurg study will come out in #DLD. Surprisingly, no significant difference in follow up comparing complicated and uncomplicated the CD patients, with some potencial medical overtreatment after surgery

A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results and Research Summary:

Percutaneous cholecystostomy should serve as a bridge to interval cholecystectomy in patients with contraindications to immediate surgery, specifically those with sepsis and acute cholecystitis, with IC ideally performed 8-13 weeks post-PC. ja.ma/4ge3GtS